139 related articles for article (PubMed ID: 4057575)
41. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
42. Steroid hormone receptors in the management of human breast cancer.
Knight WA; Osborne CK; Yochmowitz MG; McGuire WL
Ann Clin Res; 1980 Oct; 12(5):202-7. PubMed ID: 7015982
[TBL] [Abstract][Full Text] [Related]
43. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
44. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
45. Morphology of human uterine cancer in nude mice. Effects of hormone and antihormone treatment.
Zaino RJ; Satyaswaroop PG; Mortel R
Arch Pathol Lab Med; 1984 Jul; 108(7):571-8. PubMed ID: 6547322
[TBL] [Abstract][Full Text] [Related]
46. Clinical significance of estrogen and progestin receptors in ovarian cancer.
Kauppila A; Vierikko P; Kivinen S; Stenbäck F; Vihko R
Obstet Gynecol; 1983 Mar; 61(3):320-6. PubMed ID: 6823373
[TBL] [Abstract][Full Text] [Related]
47. Androgen receptors: a marker to increase sensitivity for identifying breast cancer in skin metastasis of unknown primary site.
Bayer-Garner IB; Smoller B
Mod Pathol; 2000 Feb; 13(2):119-22. PubMed ID: 10697267
[TBL] [Abstract][Full Text] [Related]
48. Long-term survival in primary breast cancer: correlation with estrogen and progesterone receptor assay results and adjuvant tamoxifen therapy.
Chrapusta SJ; Giermek J; Pieńkowski T
Med Sci Monit; 2004 Oct; 10(10):CR577-86. PubMed ID: 15448598
[TBL] [Abstract][Full Text] [Related]
49. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.
Honma N; Horii R; Iwase T; Saji S; Younes M; Takubo K; Matsuura M; Ito Y; Akiyama F; Sakamoto G
J Clin Oncol; 2008 Aug; 26(22):3727-34. PubMed ID: 18669459
[TBL] [Abstract][Full Text] [Related]
50. Phospho-serine-118 estrogen receptor-alpha expression is associated with better disease outcome in women treated with tamoxifen.
Murphy LC; Niu Y; Snell L; Watson P
Clin Cancer Res; 2004 Sep; 10(17):5902-6. PubMed ID: 15355923
[TBL] [Abstract][Full Text] [Related]
51. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
[TBL] [Abstract][Full Text] [Related]
52. The impact of tumor progesterone receptor status on optimal adjuvant endocrine therapy for postmenopausal patients with early-stage breast cancer: a decision analysis.
Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ
Cancer; 2006 Jun; 106(12):2576-82. PubMed ID: 16703595
[TBL] [Abstract][Full Text] [Related]
53. [Mechanism of action of endocrine therapy of endometrial carcinoma].
Kuramoto H; Hata H; Kato Y; Hata K; Hamano M; Anzai Y; Watanabe J; Holinka CF; Gurpide E
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1851-7. PubMed ID: 2730078
[TBL] [Abstract][Full Text] [Related]
54. [Anti-steroid hormones for uterine cancer].
Komiyama S; Nishio E; Yasue A; Hasegawa K; Udagawa Y
Nihon Rinsho; 2008 Jan; 66(1):174-81. PubMed ID: 18186261
[TBL] [Abstract][Full Text] [Related]
55. Identification of endocrine responsive breast and endometrial carcinoma using steroid hormone receptors.
Wittliff JL; Day TG; Dean WL; Allegra JC
Prog Clin Biol Res; 1988; 276():11-41. PubMed ID: 3051018
[No Abstract] [Full Text] [Related]
56. Hormone receptors in human prostate cancer.
Blankenstein MA; Bolt-de Vries J; van Aubel OG; van Steenbrugge GJ
Scand J Urol Nephrol Suppl; 1988; 107():39-45. PubMed ID: 3287596
[TBL] [Abstract][Full Text] [Related]
57. Effect of tamoxifen on steroid hormone receptors and creatine kinase activity in human endometrial carcinoma.
Iacobelli S; Scambia G; Atlante G; Landoni F; Sismondi P; Vecchio FM
Eur J Cancer Clin Oncol; 1986 Jan; 22(1):105-10. PubMed ID: 3956553
[TBL] [Abstract][Full Text] [Related]
58. Heterogeneity of progesterone receptor distribution in human endometrial adenocarcinoma.
Zaino RJ; Clarke CL; Mortel R; Satyaswaroop PG
Cancer Res; 1988 Apr; 48(7):1889-95. PubMed ID: 3280122
[TBL] [Abstract][Full Text] [Related]
59. Tamoxifen and endometrial carcinoma: alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia.
Carlson JA; Allegra JC; Day TG; Wittliff JL
Am J Obstet Gynecol; 1984 May; 149(2):149-53. PubMed ID: 6232850
[TBL] [Abstract][Full Text] [Related]
60. Hormone receptors in endometrial cancer.
Gurpide E
Cancer; 1981 Jul; 48(2 Suppl):638-41. PubMed ID: 7023668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
